drugset / Trial / NCT00169572

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

NCT00169572

Phase 2 Completed 492 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was designed to assess the safety and efficacy of an investigational agent administered in addition to a standard anti-emetic regimen for the treatment of chemotherapy induced nausea and vomiting.

Timeline

Start
2005-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified
Subject Casopitant Small molecule Oral
Background Dexamethasone Small molecule
Background Ondansetron Other / unclassified